Call to arrange a consultation
+1 416 777 0888

Mingquan Zhang, Ph.D.

Associate

Mingquan’s practice focuses on patent and trademark litigation, including proceedings under the Patented Medicines (Notice of Compliance) Regulations, patent infringement / validity proceedings under the Patent Act, and trademark actions.  In addition, Mingquan advises clients on patent issues such as infringement and validity.  Prior to law school, Mingquan received a B.Sc. in analytical chemistry and a Ph.D. in bioanalytical chemistry.

Education

  • B.SC., Peking University
  • PH.D., University of Toronto
  • J.D., University of Toronto

Bar Admission

  • Ontario, 2013

Mingquan Zhang, Ph.D.

Recent Cases

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,402,894 (saxagliptin)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,762,013 and 2,620,380 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,937,365 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,620,380 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,631,646 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,667,654 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,709,997 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,014 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,358 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,819,967 (pirfenidone)

Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), TMA157,162 (ENERGIZER) and TMA740,338 (ENERGIZER)

Patent impeachment case regarding Patent No. 2,329,829 (trastuzumab)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,366,785 and 2,476,934 (etanercept)

Patent infringement case regarding Patent Nos. 2,475,076 and 2,522,321 (Hard Wood Floor Panels and Manufacturing)

Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), 157,162 (ENERGIZER) and 740,338 (ENERGIZER)

More people

Interested in joining the team?

We are always on the lookout for talented individuals.

View Careers